Market Research Trending

  The growing incidence and prevalence of genetic disorders are supporting the growth of the global SNP genotyping and analysis market. For instance, according to the Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018, the number of people with cystic fibrosis increased from 21,421 in 2003 to 30,775 in 2018. Increasing adoption of a strategic alliance among key players is again fostering the growth of the SNP genotyping and analysis market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database. Growing technological advancement is another key factor fostering the growth of the market. The field of SNP or Single Nucleation Polymorphism genomics is a method to study and profile the genetic differences of SNPs along with testing individuals against a referen...

  The growing incidence and prevalence of genetic disorders are supporting the growth of the global SNP genotyping and analysis market. For instance, according to the Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018, the number of people with cystic fibrosis increased from 21,421 in 2003 to 30,775 in 2018. Increasing adoption of a strategic alliance among key players is again fostering the growth of the SNP genotyping and analysis market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database. Growing technological advancement is another key factor fostering the growth of the market. The field of SNP or Single Nucleation Polymorphism genomics is a method to study and profile the genetic differences of SNPs along with testing individuals against a referen...